HPV

Low Incidence of Cervical Cancer for HPV-Negative Women

Low Incidence of Cervical Cancer for HPV-Negative Women

Human papillomavirus (HPV)-negative women have low long-term incidence of cervical cancer and CIN3+, which supports an extension of the cervical screening interval beyond five years for some, according to a study.

Outcomes Are Better for HPV16-Associated Oropharyngeal Cancer, but Not for Other HPV Strains

Outcomes Are Better for HPV16-Associated Oropharyngeal Cancer, but Not for Other HPV Strains

By

Patients with oropharyngeal tumors that harbor HPV16 have higher 5-year survival and lower recurrence rates than patients with tumors that harbor other HPV strains or are HPV-negative.

Poor Oral Health Associated With OPSCC Regardless of HPV Status

Poor Oral Health Associated With OPSCC Regardless of HPV Status

By

Despite a higher risk for HPV-negative orophayngeal squamous cell carcinoma (OPSCC), poor oral health appears to be associated with OPSCC regardless of HPV status.

HPV Vaccination Program Reduces Cervical Cell Anomalies in Young Women

HPV Vaccination Program Reduces Cervical Cell Anomalies in Young Women

By

Fewer cervical cell anomalies were present on cervical cancer screens of young women in Canada who received the HPV vaccine through a school-based program.

CDC: Most HPV-Linked Cancers Are Preventable

CDC: Most HPV-Linked Cancers Are Preventable

Cervical cancer, and oropharyngeal cancers in men, account for most HPV-associated cancers.

ASCO Offers Guidelines for Increasing HPV Vaccine Uptake

ASCO Offers Guidelines for Increasing HPV Vaccine Uptake

Oncologists should raise awareness of HPV-related cancers and role of vaccinations

High-risk HPV Infection Increases Risk for Anal Cancer

By

Anal cancer is associated with human papillomavirus (HPV) infection, and some women are at increased likelihood of have both diseases.

Imaging, Physical Examination Find Most Recurrences of HPV-positive Oropharyngeal Cancer

By

Posttreatment imaging at 3 months and physical examinations during the 6 months following treatment can detect most recurrences in patients treated with definitive radiation therapy for HPV-associated oropharyngeal cancer.

Serum HPV Antibody Levels May Be a Biomarker for Recurrent HPV-associated Oropharyngeal Cancer

By

Among patients treated for oropharyngeal cancers linked to human papillomavirus (HPV) infection, at least 1 HPV-infection antibody could help identify those patients at risk for a recurrence of the cancer.

β-Genus Human Papillomavirus Linked to Skin Cancer Risk

β-Genus Human Papillomavirus Linked to Skin Cancer Risk

HPV subtypes 5, 8, 17, 20, and 38 have been associated with a significant increased cancer risk.

HPV16 detection after oropharyngeal cancer treatment may increase risk for recurrence

HPV16 detection after oropharyngeal cancer treatment may increase risk for recurrence

Patients with oropharyngeal cancer who were found to have detectable traces of human papillomavirus type 16 (HPV16) in their saliva.

Blood antibodies may predict survival of HPV-positive oropharyngeal cancer

By

The presence of certain human papillomavirus (HPV)-16 antibodies in the blood is associated with improved survival rates for patients with HPV-related oropharyngeal carcinoma.

HPV vaccine may be effective with just one dose, not three

HPV vaccine may be effective with just one dose, not three

One dose of the HPV vaccine may be sufficient to protect girls from cervical cancer rather than the currently recommended three doses.

Persistent HPV16 in Oral Rinses Signals Poor Prognosis for HPV-Positive Oropharyngeal Carcinoma

Persistent HPV16 in Oral Rinses Signals Poor Prognosis for HPV-Positive Oropharyngeal Carcinoma

By

Detection of human papillomavirus (HPV)16 DNA in oral rinses following treatment for HPV-positive oropharyngeal carcinoma could be a potential tool for long-term tumor surveillance, a study concluded at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting.

HPV vaccination of girls offers benefits to men but does not reduce risk of some cancers

HPV vaccination of girls offers benefits to men but does not reduce risk of some cancers

Men benefit indirectly but not from cancer risk associated with the virus.

HPV vaccine may be cost-effective strategy for preventing oropharyngeal cancer in males

HPV vaccine may be cost-effective strategy for preventing oropharyngeal cancer in males

Human papillomavirus (HPV) vaccine may be a cost-effective approach for preventing squamous cell oropharyngeal cancer.

HPV-16 infection is associated with improved survival in advanced esophageal cancer

HPV-16 infection is associated with improved survival in advanced esophageal cancer

Improved survival and treatment response was seen in HPV-16 positive patients.

HPV-positive oropharyngeal cancer has cure potential

HPV-positive oropharyngeal cancer has cure potential

By

A prospective study found that patients with human papillomavirus-related disease had better treatment response than HPV-negative patients.

Alterations in head and neck cancers associated with HPV infection are found

By

Investigators have uncovered genomic differences, with potentially important clinical implications, in head and neck cancers caused by infection with the human papillomavirus.

HPV vaccination often administered at less beneficial age

HPV vaccination often administered at less beneficial age

Researchers note that CDC recommends vaccination at age 11 or 12, but only half of girls receiving the vaccination get it at the proper age.

Guidance issued for HPV test As Pap test alternative

Guidance issued for HPV test As Pap test alternative

ACOG still recommending women aged 30 to 65 be screened with Pap or HPV/Pap combination, however.

FDA approves 9-valent HPV vaccine to prevent certain cancers

FDA approves 9-valent HPV vaccine to prevent certain cancers

The FDA has approved Gardasil 9 for the prevention of anal, cervical, vaginal, and vulvar cancers.

Cervical cancer incidence higher in states with lower proportion of HPV vaccination rates

Cervical cancer incidence higher in states with lower proportion of HPV vaccination rates

Number of adolescent girls receiving the human papillomavirus (HPV) vaccine much lower in states with higher rates of cervical cancer.

Novel Pap test may be more accurate in detecting cervical cancer

By

A clinical trial is underway that may provide women with a more accurate way to detect cervical cancer.

HPV vaccine shows sustained efficacy, immunogenicity, and safety in long-term study

By

A long-term follow-up study shows the sustained efficacy, immunogenicity, and safety of GlaxoSmithKline's human papillomavirus (HPV) vaccine Cervarix. Women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine were followed for more than 9 years, and vaccine efficacy (VE) against incident infection was 100%.

Blood and saliva tests help predict return of human papillomavirus (HPV)-linked oral cancers

By

Physicians have developed blood and saliva tests that help accurately predict recurrences of HPV-linked oral cancers in a substantial number of patients. The tests screen for DNA fragments of the HPV shed from cancer cells lingering in the mouth or other parts of the body.

Noncervical cancers related to HPV on the increase in Canada

Noncervical cancers related to HPV on the increase in Canada

Registry data show increase in incidence rates of HPV-related oropharyngeal and anal cancers are up in Canada.

HPV-positive status tied to oropharyngeal cancer survival

HPV-positive status tied to oropharyngeal cancer survival

Human papillomavirus (HPV) positivity is associated with improved survival after disease progression, according to a study.

Treacherous immune genes can cause cancer after viral infection

By

Infection with human papillomavirus is known to induce cancer. Many of the mutations that cause this virally induced cancer occur in a family of genes that normally combats viral infections, according to new research.

New HPV test sensitive for cervical cancer

New HPV test sensitive for cervical cancer

The new human papillomavirus (HPV) test has higher sensitivity and specificity than Pap testing for cervical cancer, according to an ideas and opinion piece published online.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs